Exchange Traded Concepts, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 3,568 shares of ALNY stock, worth $849,112. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,568
Previous 3,432 3.96%
Holding current value
$849,112
Previous $833,000 17.77%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
BUY
$233.81 - $287.01 $31,798 - $39,033
136 Added 3.96%
3,568 $981,000
Q2 2024

Aug 13, 2024
SELL
$143.31 - $247.0 $51,018 - $87,932
-356 Reduced 9.4%
3,432 $833,000
Q1 2024

Apr 15, 2024
SELL
$146.51 - $198.2 $238,078 - $322,075
-1,625 Reduced 30.02%
3,788 $566,000
Q4 2023

Jan 05, 2024
BUY
$151.41 - $196.57 $308,876 - $401,002
2,040 Added 60.48%
5,413 $1.04 Million
Q3 2023

Oct 18, 2023
SELL
$170.77 - $211.65 $829,942 - $1.03 Million
-4,860 Reduced 59.03%
3,373 $597,000
Q2 2023

Jul 20, 2023
SELL
$185.01 - $212.05 $2.41 Million - $2.76 Million
-13,035 Reduced 61.29%
8,233 $1.56 Million
Q1 2023

Apr 12, 2023
BUY
$182.66 - $235.53 $2.54 Million - $3.27 Million
13,900 Added 188.65%
21,268 $4.26 Million
Q4 2022

Jan 17, 2023
SELL
$185.53 - $241.31 $134,323 - $174,708
-724 Reduced 8.95%
7,368 $1.75 Million
Q3 2022

Oct 07, 2022
SELL
$138.54 - $232.0 $715,004 - $1.2 Million
-5,161 Reduced 38.94%
8,092 $1.62 Million
Q2 2022

Jul 20, 2022
SELL
$120.42 - $169.29 $33,597 - $47,231
-279 Reduced 2.06%
13,253 $1.93 Million
Q1 2022

Apr 26, 2022
BUY
$127.18 - $173.91 $587,317 - $803,116
4,618 Added 51.81%
13,532 $2.21 Million
Q4 2021

Jan 13, 2022
SELL
$159.56 - $209.29 $28,242 - $37,044
-177 Reduced 1.95%
8,914 $1.51 Million
Q3 2021

Oct 18, 2021
SELL
$169.75 - $207.73 $338,990 - $414,836
-1,997 Reduced 18.01%
9,091 $1.72 Million
Q2 2021

Jul 30, 2021
BUY
$128.63 - $176.89 $44,248 - $60,850
344 Added 3.2%
11,088 $1.88 Million
Q1 2021

Apr 20, 2021
BUY
$126.83 - $175.69 $427,163 - $591,723
3,368 Added 45.66%
10,744 $1.52 Million
Q4 2020

Jan 19, 2021
BUY
$122.97 - $147.0 $569,228 - $680,463
4,629 Added 168.51%
7,376 $959,000
Q3 2020

Oct 30, 2020
BUY
$121.19 - $165.49 $154,153 - $210,503
1,272 Added 86.24%
2,747 $400,000
Q2 2020

Jul 15, 2020
BUY
$104.21 - $156.44 $80,033 - $120,145
768 Added 108.63%
1,475 $218,000
Q1 2020

Apr 14, 2020
BUY
$93.12 - $133.99 $30,077 - $43,278
323 Added 84.11%
707 $77,000
Q4 2019

Jan 22, 2020
BUY
$74.51 - $124.23 $28,611 - $47,704
384 New
384 $44,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email